Abstract
Though hypertension is a serious health problem, the inhibition of the angiotensin-I converting enzyme (ACE) provides a means to treat and manage it. In the present work work, we investigated the ACE-inhibitory activity of crude proteins and protein hydrolysates from Job’s tears (Coix lacryma-jobi L.). ACE inhibition of 22.15 ± 0.94% was observed with 400 µg of protein from Job’s tears as compared to captopril, a common ACE inhibitor, equalled to 53.7 ± 2.3 nmol captopril equivalent per mg of protein (IC50 of captopril towards ACE was 4.8 nmol). The crude proteins from Job’s tears were enzymatically hydrolysed for 1, 2, and 3 h (E/S of 1:20 by weight) using commercial proteolytic enzymes including Alcalase, Papain, Pronase, and Trypsin. All hydrolysates exhibited increased ACE-inhibitory activity. The protein hydrolysates (400 µg) prepared using Pronase for 2 h (CLPrH-2h) exhibited the highest inhibitory activity (78.38 ± 0.23% or 190.0 ± 0.5 nmol captopril equiv. per mg protein) and were ~3.5 times more active as compared to crude proteins. Fractionation of the peptides was performed using semi-preparative reverse-phase high-performance liquid chromatography (RP-HPLC), and all the fractions exhibited ACE-inhibitory activity. The most active fraction was F2 (41.58% inhibition) which was ~7.5 times more active than the crude proteins. These results suggested that seeds from Job’s tears could be an interesting source for developing functional foods with antihypertensive properties.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.